ACI - NYSE

Albertsons Companies, Inc.

ACI·NYSE

$15.71

-0.29%

Consumer DefensiveGrocery Stores

Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores. As of February 26, 2022, it operated 2,276 stores under various banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's Food Lovers Market; and 1,722 pharmacies, 1,317 in-store branded coffee shops, 402 adjacent fuel centers, 22 distribution centers, and 20 manufacturing facilities, as well as various digital platforms. The company was founded in 1860 and is headquartered in Boise, Idaho.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$7.77B

EPS0.4000

P/E Ratio39.28

Earnings Date07/21/2026

26.77B

Assets

-9%

3Y-7.0%

5Y-9.0%

10Y+13.0%

24.93B

Total Liabilities

-4%

3Y-8.0%

5Y-11.0%

10Y+11.0%

1.84B

Total Equity

-46%

3Y+14.0%

5Y+39.0%

10Y+34.0%

Albertsons Companies, Inc. Funding & Solvency Profile

ACI · NYSE

Current Assets

Cash & Cash Equivalents198.60M

Net Receivables932.60M

Inventory5.17B

Other Current Assets42.50M

Total Current Assets7 B

Non-Current Assets

Property, Plant & Equipment16.01B

Goodwill & Intangible Assets3.36B

Long-Term Investments0.00

Other Non-Current Assets687.00M

Total Non-Current Assets17 B

Total Assets

26.77B

Financial Health Analysis

Current Ratio

0.86x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

13.58x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-1108300000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

25% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Albertsons Companies, Inc. Balance Sheet

ACI • NYSE

Albertsons Companies, Inc. Balance Sheet	Feb 2026	Feb 2025	Feb 2024	Feb 2023	Feb 2022	Feb 2021	Feb 2020	Feb 2019	Feb 2018	Feb 2017	Feb 2016	Feb 2015
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	198.6M	297.9M	188.7M	455.8M	3B	1.8B	478.9M	967.7M	680.8M	1.2B	593M	1.1B
Short-Term Investments	0.0	41.3M	23.3M	21.4M	14.4M	11.9M	13.5M	23.1M	24.5M	21.6M	0.0	0.0
Cash & Short-Term Investments	198.6M	339.2M	212M	477.2M	3B	1.8B	492.4M	990.8M	705.3M	1.2B	593M	1.1B
Net Receivables	932.6M	834.8M	724.4M	687.6M	560.6M	550.9M	525.3M	586.2M	615.3M	631M	647.8M	631.9M
Accounts Receivables	932.6M	815.7M	703.2M	665.9M	540.1M	526.3M	502.8M	586.2M	615.3M	631M	647.8M	601.5M
Other Receivables	0.0	19.1M	21.2M	21.7M	20.5M	24.6M	22.5M	0.0	0.0	0.0	0.0	30.4M
Inventory	5.2B	5B	4.9B	4.8B	4.5B	4.3B	4.4B	4.3B	4.4B	4.5B	4.4B	4.2B
Prepaids	368.1M	338.8M	370.3M	302.7M	301.6M	317.2M	255M	316.2M	368.6M	345.3M	362.4M	392.9M
Other Current Assets	42.5M	57.2M	35.6M	20.9M	36.4M	39.1M	106.1M	24M	38.3M	112.1M	88.3M	797.5M
Total Current Assets	6.7B	6.6B	6.3B	6.3B	8.4B	7B	5.7B	6.3B	6.1B	6.8B	6.1B	7.1B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	16B	16B	15.6B	15.2B	15.3B	15.4B	15.1B	9.9B	10.8B	11.5B	11.8B	12B
Goodwill	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.1B	1B
Intangible Assets	2.2B	2.3B	2.4B	2.5B	2.3B	2.1B	2.1B	2.8B	3.1B	3.5B	3.9B	4.2B
Goodwill & Intangible Assets	3.4B	3.5B	3.6B	3.7B	3.5B	3.3B	3.3B	4B	4.3B	4.7B	5B	5.3B
Long-Term Investments	0.0	239.6M	240.5M	350.9M	133.3M	110.2M	129.8M	125.3M	153.6M	147.5M	270.2M	341M
Tax Assets	0.0	2.6B	2.6B	2.6B	2.6B	2.8B	2.5B	738.1M	730.7M	0.0	0.0	0.0
Other Non-Current Assets	687M	473.7M	505.7M	642.7M	879.3M	779.4M	524.2M	522.2M	414M	636.9M	526.7M	1B
Total Non-Current Assets	20.1B	22.7B	22.5B	22.5B	22.4B	22.4B	21.5B	15.3B	16.4B	17B	17.7B	18.7B
Total Assets	26.8B	29.3B	28.8B	28.8B	30.8B	29.4B	27.3B	21.5B	22.5B	23.8B	23.8B	25.8B
LIABILITIES
CURRENT LIABILITIES
Total Payables	4B	4.1B	4.2B	4.2B	4.2B	3.5B	2.9B	2.9B	2.8B	3B	2.8B	2.9B
Accounts Payable	4B	4.1B	4.2B	4.2B	4.2B	3.5B	2.9B	2.9B	2.8B	3B	2.8B	2.8B
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.4M
Accrued Expenses	1.3B	1.4B	1.3B	1.3B	1.6B	1.5B	1.1B	1.1B	984.1M	1B	1B	1.1B
Short Term Debt	1.3B	600K	962.8M	1.7B	1.5B	817.7M	784.5M	148.8M	168.2M	318.5M	334.7M	624M
Capital Lease Obligations (Current)	0.0	762.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	393.9M	325.4M	382.3M	344.6M	339.1M	318.1M	309M	323.5M	348.8M	304.1M	287.5M
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7M	13.9M	14.4M	0.0	25.4M
Other Current Liabilities	1.2B	1B	958.3M	1.2B	1.1B	1B	1.1B	1B	1B	1.4B	1.1B	1.5B
Total Current Liabilities	7.8B	7.3B	7.5B	8.4B	8.3B	6.8B	5.9B	5.2B	5B	5.7B	5.2B	6.2B
NON-CURRENT LIABILITIES
Long Term Debt	8.4B	7.4B	7.4B	7.4B	7.9B	9.2B	7.9B	9.8B	11.7B	11.2B	11B	11.1B
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9M	58.6M	0.0	0.0	256M
Deferred Tax Liabilities (Non-Current)	630.6M	3.4B	3.4B	3.4B	3.4B	3.3B	3.1B	1.3B	1.3B	1.5B	1.5B	1.8B
Other Non-Current Liabilities	2.4B	1.9B	1.9B	2B	2.1B	2.7B	2B	3.1B	2.4B	3.1B	3.6B	3.4B
Total Non-Current Liabilities	17.1B	18.7B	18.6B	18.7B	19.4B	21.2B	19.1B	14.9B	16.1B	16.6B	17B	17.4B
Capital Lease Obligations	5.6B	6.8B	5.9B	5.8B	5.9B	6.1B	6B	0.0	0.0	0.0	0.0	0.0
Total Liabilities	24.9B	25.9B	26B	27.1B	27.7B	28.1B	25B	20.1B	21.1B	22.4B	22.2B	23.6B
SHAREHOLDERS' EQUITY
Treasury Stock	-1.9B	-386.7M	-304.2M	-352.2M	-1.6B	-1.9B	-25.8M	-25.8M	0.0	0.0	0.0	0.0
Common Stock	6M	6M	5.9M	5.9M	5.9M	5.9M	2.8M	2.8M	2.8M	0.0	0.0	0.0
Additional Paid-In Capital	2.2B	2.2B	2.1B	2.1B	2B	1.9B	1.8B	1.8B	1.8B	2B	2B	1.8B
Retained Earnings	1.4B	1.5B	828.2M	-185M	2.6B	1.3B	592.3M	-431.8M	-569M	-615.3M	-242M	260.2M
Accumulated Other Comprehensive Income/Loss	83.2M	94.7M	88M	69.3M	69M	63.5M	-118.5M	91.3M	191.1M	-12.8M	-112.7M	59.6M
Total Stockholders' Equity	1.8B	3.4B	2.7B	1.6B	3B	1.3B	2.3B	1.5B	1.4B	1.4B	1.6B	2.2B
Total Equity	1.8B	3.4B	2.7B	1.6B	3B	1.3B	2.3B	1.5B	1.4B	1.4B	1.6B	2.2B
SUMMARY
Total Liabilities & Equity	26.8B	29.3B	28.8B	28.8B	30.8B	29.4B	27.3B	21.5B	22.5B	23.8B	23.8B	25.8B
Total Investments	0.0	280.9M	263.8M	372.3M	147.7M	122.1M	143.3M	148.4M	178.1M	169.1M	270.2M	341M
Total Debt	15.3B	14.2B	14.2B	15B	15.3B	16.1B	14.7B	10.6B	12.5B	12.3B	12.2B	12.6B
Net Debt	15.1B	13.9B	14.1B	14.6B	12.4B	14.3B	14.2B	9.6B	11.9B	11.1B	11.6B	11.4B
Shares Outstanding	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287	549,425,287

SEC Filings

ACI - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-K 10-K 2026 FY FY	April 27, 2026	February 28, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 14, 2026	April 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 27, 2026	February 25, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 02, 2026	February 02, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 22, 2026	January 22, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	January 07, 2026	November 29, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 07, 2026	January 07, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 14, 2025	November 12, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 10, 2025	November 10, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 21, 2025	October 21, 2025	2025	View Filing

Showing 1 to 10 of 199 filings

Related Guides

Blog Categories

Continue your ACI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.